Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2196-8837
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers ; day:8 ; month:9 ; year:2020 ; pages:1-8
Journal of racial and ethnic health disparities ; (8.9.2020), 1-8

Creator
Sarangarajan, Rangaprasad
Winn, Robert
Kiebish, Michael A.
Bountra, Chas
Granger, Elder
Narain, Niven R.
Contributor
SpringerLink (Online service)

DOI
10.1007/s40615-020-00853-0
URN
urn:nbn:de:101:1-2020102821180636820815
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Sarangarajan, Rangaprasad
  • Winn, Robert
  • Kiebish, Michael A.
  • Bountra, Chas
  • Granger, Elder
  • Narain, Niven R.
  • SpringerLink (Online service)

Other Objects (12)

Angiotensin-I-Converting-Enzyme [Angiotensin-Converting-Enzyme] bei Lungenerkrankungen und Sekundärerkrankungen

Hochschulschrift

Angiotensin-I-Converting-Enzyme [Angiotensin-Converting-Enzyme] bei Lungenerkrankungen und Sekundärerkrankungen

Veränderungen des Angiotensin-I-Converting-Enzyms [Angiotensin-Converting-Enzyms] bei Schilddrüsenfunktionsstörungen

Hochschulschrift

Veränderungen des Angiotensin-I-Converting-Enzyms [Angiotensin-Converting-Enzyms] bei Schilddrüsenfunktionsstörungen

Angiotensin-converting-enzyme-Hemmung

Konferenzschrift | Kongress

Angiotensin-converting-enzyme-Hemmung

Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis

Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis

Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema

Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels

Der Katalysemechanismus des Angiotensin Converting Enzyme

Der Katalysemechanismus des Angiotensin Converting Enzyme

Das Angiotensin-Converting Enzym bei Cholestasen

Hochschulschrift

Das Angiotensin-Converting Enzym bei Cholestasen

Angiotensin-Converting-Enzyme - Bestimmung im Seminalplasma

Hochschulschrift

Angiotensin-Converting-Enzyme - Bestimmung im Seminalplasma

Morbus Gaucher und Angiotensin-Converting-Enzyme

Hochschulschrift

Morbus Gaucher und Angiotensin-Converting-Enzyme

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers

Related objects